Cabozantinib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor, a drug used as a therapy for several ...

Medically reviewed by Katlein Franca, MD Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Michael Hofman presented an in-depth ...

A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell ...

Belzutifan, a hypoxia-inducible factor 2α inhibitor, showed clinical activity in clear-cell renal-cell carcinoma ... as assessed by Functional Assessment of Cancer Therapy Kidney Symptom Index ...

The findings were published in JCO Precision Oncology. Kidney cancer accounts for about 3–5% of all cancers; clear cell renal cancer makes up about 75% of all kinds of kidney cancers.

Clear cell papillary renal cell carcinoma, or clear cell papillary renal cell tumor (CCPRCT), is a type of kidney cancer. It overlaps with both clear cell and papillar renal cell carcinomas but ...

The novel drug, zanzalintinib (XL092), showed promising cancer-fighting abilities in patients with advanced clear-cell renal cell carcinoma (ccRCC), according to initial results from the STELLAR-001 ...

Zanzalintinib monotherapy showed promising antitumor activity among patients with previously treated clear ... cell renal cell carcinoma, according to findings presented at International Kidney ...

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma ... associate dean for cancer programs at the University ...

More information: "Adjuvant everolimus (EVE) in patients (pts) with completely resected very high-risk renal cell cancer (RCC) and clear cell histology: results from the phase III SWOG S0931 ...